Type
. The result patterns of ML Flow and ELISA (PGL-I) serologic tests in leprosy-endemic and non-endemic areas. Revista da Sociedade Brasileira de Medicina Tropical. 2008;41 Suppl 2:19-22.
Type
. Leprosy serology using PGL-I: a systematic review. Revista da Sociedade Brasileira de Medicina Tropical [Internet]. 2008;41 Suppl 2:11-8. Available from: http://www.scielo.br/pdf/rsbmt/v41s2/en_v41s2a04.pdf
Type
. PGL-I leprosy serology. Revista da Sociedade Brasileira de Medicina Tropical. 2008;41 Suppl 2:3-5.
Type
. Leprosy. BMJ clinical evidence [Internet]. 2007;2007. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2943824/pdf/2007-0915.pdf
Type
. [Medical activities under adverse conditions. The Dutch Foundation for Leprosy control]. Nederlands tijdschrift voor geneeskunde. 1991;135(46):2183-5.
Type
. Use of thalidomide in leprosy. BMJ (Clinical research ed.) [Internet]. 1991;303(6809):1062-3. Available from: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1670367/pdf/bmj00132-0059e.pdf
Type
. Hepatitis B virus (HBV) and human immunodeficiency virus (HIV) infection in Spanish leprosy patients. Postgraduate medical journal. 1991;67(791):857-8.
Type
. Ocular lesions in leprosy. Annals of ophthalmology. 1991;23(8):297-303.
Type
. Thyroxine may cure leprosy, fungal diseases and metabolic cataract. Medical hypotheses. 1991;35(4):315.
Type
. Some indices pertaining to the leprosy control programme in Tamil Nadu, based on data from a random sample of fourteen government control units. The Indian journal of medical research. 1991;93:208-16.